Expert scientists and clinicians, who are dedicated to understanding prostate cancer, come together through the Institute for Prostate Cancer Research (IPCR) to devise therapies and new technologies in hopes of one day finding a cure.
The institute is a collaborative effort of UW Medicine and Fred Hutchinson Cancer Center. A natural outgrowth of established research and clinical collaborations, the IPCR brings together a world-renowned team whose mission is to understand the causes of prostate cancer and its progression, develop new prevention strategies, devise innovative diagnostics and improve survival and quality of life.
The IPCR calls on the strength of more than 40 scientists and scientist-clinicians in multiple disciplines. Many are international leaders in their fields.
Together these researchers have already identified and/or assembled up to 80 percent of the genes expressed in prostate cancer, developed one of the largest serum and tissue banks in the world, undertaken some of the most advanced studies of bone biology and skeletal metastases, assembled information and genotypes for more than 300 families with hereditary prostate cancer, and developed many new therapeutic strategies.
Since the IPCR’s formation, its faculty members have been awarded more than $40 million in research grants from the National Institutes of Health and other federal agencies. This includes one of only seven prostate cancer Specialized Program of Research Excellence (SPORE) grants nationwide from the National Cancer Institute to study prostate cancer progression.
IPCR faculty members also have received many other individual grants to study numerous aspects of prostate cancer. Receiving this level of private and federal funding constitutes a tremendous accomplishment and demonstrates the excellence of our faculty members and their work.
Together, these scientists and clinicians provide hope for men with prostate cancer and their families in the Northwest and the world.
Help Us Find a Cure for Prostate Cancer
Private support is essential to fund research in laboratory, clinical and population settings, and ensures that the most talented researchers can focus their efforts on finding ways to prevent and cure prostate cancer.
Investing in the IPCR is a unique opportunity to build a lasting legacy in the battle against this devastating cancer.
Your support helps us to:
- Fund innovative, high-risk and high-gain research, such as testing novel approaches for prostate cancer prevention and finding and exploiting new therapeutic targets.
- Recruit and retain the best and brightest scientists and physicians in the field of prostate cancer research and care. Invest in infrastructure to support research.
- Invest in infrastructure to support research.